Patients using GLP-1 agonists for weight loss can experience muscle mass loss, similar to post-weight loss surgery complications, according to obesity specialists. “Dismissing the importance of muscle loss can create a disconnect between patients’ increased awareness of muscle and the role it plays in health," researchers wrote in The Lancet Diabetes & Endocrinology.
Full Story: Medscape (1/7)